IGM Biosciences Inc. (IGMS) Tops Q4 EPS by 34c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($1.19), $0.34 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $304.78 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MIND Technology (MIND) Misses Q1 EPS by 5c
• Independent Bank receives regulatory approval for HCB Financial acquisition